KPV
Prescription OnlyOverview
KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). It is a niche anti-inflammatory peptide with limited but stable prescription availability in Australia.
Australian Scheduling
Schedule 4 (Prescription Only). Stable classification. Limited regulatory attention due to its niche status.
Access Pathway
Available through a small number of specialist telehealth providers. 3 identified Australian providers. Not widely compounded but available on request.
For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.